Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis

類似資料

• Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
  著者:: Mehta, Puja, 等
  出版事項: (2021)
• B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
  著者:: Mehta, Puja, 等
  出版事項: (2020)
• Thrombose und COVID-19
  著者:: Tzaneva, Stanislava
  出版事項: (2021)
• Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis
  著者:: Ageno, Walter, 等
  出版事項: (2018)
• Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
  著者:: Dutt, Tina, 等
  出版事項: (2020)